β-Adrenoceptor stimulation potentiates insulin-stimulated PKB phosphorylation in rat cardiomyocytes via cAMP and PKA

British Journal of Pharmacology

Volumn 160, Issue 1, 2010, Pages 116-129

  Stuenæs, Jorid T ^a   Bolling, Astrid ^a   Ingvaldsen, Ada ^a   Rommundstad, Camilla ^a,b   Sudar, Emina ^a,c   Lin, Fang Chin ^a,d   Lai, Yu Chiang ^a,d   Jensen, Jørgen ^a,d  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

Author keywords

Akt; ERK; GSK 3; Heart; Hypertrophy; Phoshodiesterase; Phosphatidylinositol 3 kinase; Phospholamban; Phosphorylation; Rolipram

Indexed keywords

BETA ADRENERGIC RECEPTOR; COLLAGENASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOBUTAMINE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPRENALINE; NEUTRAL INSULIN; PHOSPHOLAMBAN; PROTEIN KINASE B; SALBUTAMOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM-BINDING PROTEINS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOBUTAMINE; DRUG SYNERGISM; ENZYME ACTIVATION; GLYCOGEN PHOSPHORYLASE; INSULIN; ISOPROTERENOL; MALE; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA;

EID: 77950956173     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00677.x     Document Type: Article

References (60)

1. Ashrafian H, Frenneaux MP, Opie LH (2007). Metabolic mechanisms in heart failure. Circulation 116 : 434 448.
2. Baillie GS, Houslay MD (2005). Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin Cell Biol 17 : 129 134.
3. 2-adrenoceptor signaling in the adult rat heart. Cardiovasc Res 57 : 694 703.
4. Bayascas JR, Sakamoto K, Armit L, Arthur JS, Alessi DR (2006). Evaluation of approaches to generate PDK1 tissue specific knock-in mice. J Biol Chem 281 : 28772 28781.
5. Beauloye C, Bertrand L, Krause U, Marsin AS, Dresselaers T, Vanstapel F et al. (2001). No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res 88 : 513 519.
6. Bertrand L, Horman S, Beauloye C, Vanoverschelde JL (2008). Insulin signalling in the heart. Cardiovasc Res 79 : 238 248.
7. Brennesvik EO, Ktori C, Ruzzin J, Jebens E, Shepherd PR, Jensen J (2005). Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline. Cell Signal 17 : 1551 1559.
8. i-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 87 : 1172 1179.
9. 2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100 : 2210 2212.
10. Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G et al. (2002). Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci USA 99 : 12333 12338.
11. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T et al. (2002). Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110 : 737 749.
12. Debosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M et al. (2006). Akt1 is required for physiological cardiac growth. Circulation 113 : 2097 2104.
13. Deming PB, Campbell SL, Baldor LC, Howe AK (2008). Protein kinase A regulates 3-phosphatidylinositide dynamics during platelet-derived growth factor-induced membrane ruffling and chemotaxis. J Biol Chem 283 : 35199 35211.
14. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS et al. (2005). The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437 : 574 578.
15. Drago GA, Colyer J (1994). Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. J Biol Chem 269 : 25073 25077.
16. Fischmeister R, Castro LR, Bi-Gerges A, Rochais F, Jurevicius J, Leroy J et al. (2006). Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 99 : 816 828.
17. Franch J, Aslesen R, Jensen J (1999). Regulation of glycogen synthesis in rat skeletal muscle after glycogen depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase. Biochem J 344 : 231 235.
18. Gilboe DP, Larson KL, Nuttal FQ (1972). Radioactive method for the assay of glycogen phosphorylase. Anal Biochem 47 : 20 27.
19. Heineke J, Molkentin JD (2006). Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7 : 589 600.
20. Houslay MD, Schafer P, Zhang KY (2005). Keynote review: phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10 : 1503 1519.
21. Huston E, Lynch MJ, Mohamed A, Collins DM, Hill EV, Macleod R et al. (2008). EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation. Proc Natl Acad Sci USA 105 : 12791 12796.
22. Jensen J (2007). More PKA independent β-adrenergic signalling via cAMP: is Rap1-mediated glucose uptake in vascular smooth cells physiologically important? Br J Pharmacol 151 : 423 425.
23. Jensen J, Brennesvik EO, Lai YC, Shepherd PR (2007). GSK-3 regulation in skeletal muscles by adrenaline and insulin: Evidence that PKA and PKB regulate different pools of GSK-3. Cell Signal 19 : 204 210.
24. Jensen J, Grønning-Wang LM, Jebens E, Whitehead JP, Zorec R, Shepherd PR (2008). Adrenaline potentiates insulin-stimulated PKB activation in the rat fast-twitch epitrochlearis muscle without affecting IRS-1 associated PI 3-kinase activity. Pflugers Arch 456 : 969 978.
25. 2-adrenergic stimulation. Circ Res 91 : 46 53.
26. Kawakami Y, Nishimoto H, Kitaura J, Maeda-Yamamoto M, Kato RM, Littman DR et al. (2004). Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem 279 : 47720 47725.
27. 2-Adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation 99 : 2458 2465.
28. 2+ influx in cardiomyocytes. Circ Res 95 : 1183 1190.
29. Lehnart SE, Wehrens XH, Reiken S, Warrier S, Belevych AE, Harvey RD et al. (2005). Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123 : 25 35.
30. Lochner A, Moolman JA (2006). The many faces of H89: a review. Cardiovasc Drug Rev 24 : 261 274.
31. Mackenzie SJ, Baillie GS, Mcphee I, Bolger GB, Houslay MD (2000). ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J Biol Chem 275 : 16609 16617.
32. Matsui T, Tao J, Del MF, Lee KH, Li L, Picard M et al. (2001). Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 : 330 335.
33. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH et al. (2002). Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277 : 22896 22901.
34. Métrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel E et al. (2008). Epac mediates β-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102 : 959 965.
35. Mora A, Davies AM, Bertrand L, Sharif I, Budas GR, Jovanovic S et al. (2003). Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia. EMBO J 22 : 4666 4676.
36. Morel E, Marcantoni A, Gastineau M, Birkedal R, Rochais F, Garnier A et al. (2005). cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res 97 : 1296 1304.
37. Morisco C, Condorelli G, Trimarco V, Bellis A, Marrone C, Condorelli G et al. (2005). Akt mediates the cross-talk between β-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 96 : 180 188.
38. Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, Sasaki T et al. (2003). Phosphoinositide 3-kinase γ-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108 : 2147 2152.
39. 2-adrenergic signalling a new role for the cPLA2. Cell Signal 17 : 141 152.
40. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D et al. (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J Biol Chem 276 : 27462 27469.
41. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A et al. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 : 474 477. (Pubitemid 28553318)
42. Ruehr ML, Russell MA, Bond M (2004). A-kinase anchoring protein targeting of protein kinase A in the heart. J Mol Cell Cardiol 37 : 653 665. (Pubitemid 39194557)
43. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 : 1098 1101.
44. Schwartzbauer G, Robbins J (2001). The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 276 : 35786 35793. (Pubitemid 37384383)
45. Shepherd PR (2005). Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol Scand 183 : 3 12.
46. Shepherd PR, Withers DJ, Siddle K (1998). Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333 : 471 490. (Pubitemid 28398511)
47. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J et al. (2000). The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19 : 2537 2548. (Pubitemid 30323543)
48. Shiojima I, Walsh K (2006). Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20 : 3347 3365. (Pubitemid 44969154)
49. Steinberg SF (1999). The molecular basis for distinct β-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85 : 1101 1111.
50. 2-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts. J Mol Cell Cardiol 37 : 407 415.
51. 2+-lowering, G protein-independent mechanism. Pharmacol Toxicol 78 : 28 36. (Pubitemid 26041537)
52. Sugden PH, Fuller SJ, Weiss SC, Clerk A (2008). Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 153 (Suppl. 1 S137 S153. (Pubitemid 351341012)
53. Tseng YT, Yano N, Rojan A, Stabila JP, Mcgonnigal BG, Ianus V et al. (2005). Ontogeny of phosphoinositide 3-kinase signaling in developing heart: effect of acute β-adrenergic stimulation. Am J Physiol Heart Circ Physiol 289 : H1834 H1842.
54. Vanhaesebroeck B, Alessi DR (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 (Pt 3 561 576. (Pubitemid 30171014)
55. Wymann MP, Marone R (2005). Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Curr Opin Cell Biol 17 : 141 149. (Pubitemid 40380937)
56. 2 adrenoceptor subtype-specific signaling in cardiac myocytes. Proc Natl Acad Sci USA 102 : 909 914. (Pubitemid 40282764)
57. Yano N, Ianus V, Zhao TC, Tseng A, Padbury JF, Tseng YT (2007). A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes. Am J Physiol Heart Circ Physiol 293 : H385 H393. (Pubitemid 47105094)
58. Zheng M, Zhu W, Han Q, Xiao RP (2005). Emerging concepts and therapeutic implications of β-adrenergic receptor subtype signaling. Pharmacol Ther 108 : 257 268. (Pubitemid 41691867)
59. 2-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 98 : 1607 1612. (Pubitemid 32165546)
60. 2+/ calmodulin kinase II. J Clin Invest 111 : 617 625. (Pubitemid 36278580)